HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Camilla Gesi Selected Research

Neurodevelopmental Disorders

1/2016A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Camilla Gesi Research Topics

Disease

6Separation Anxiety (Separation Anxiety Disorder)
01/2017 - 09/2005
4Schizophrenia (Dementia Praecox)
01/2024 - 01/2019
4Mental Disorders (Mental Disorder)
02/2023 - 09/2005
3Mood Disorders (Mood Disorder)
01/2019 - 01/2010
3Bipolar Disorder (Manic Depressive Psychosis)
01/2018 - 01/2010
3Panic Disorder (Panic Attack)
01/2010 - 09/2005
2Cognitive Dysfunction
05/2024 - 01/2019
2Anxiety Disorders (Anxiety Disorder)
11/2019 - 05/2015
2Substance-Related Disorders (Drug Abuse)
11/2019 - 01/2018
1Anhedonia
05/2024
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
02/2023
1Major Depressive Disorder (Major Depressive Disorders)
01/2021
1Inflammation (Inflammations)
01/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016
1Neurodevelopmental Disorders
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
04/2014
1Non-ST Elevated Myocardial Infarction
04/2014
1ST Elevation Myocardial Infarction
04/2014
1Mania (Manias)
05/2012
1Depressive Disorder (Melancholia)
11/2009

Drug/Important Bio-Agent (IBA)

3Antidepressive Agents (Antidepressants)IBA
05/2024 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2010 - 04/2008
2Neurotransmitter Agents (Neurotransmitter)IBA
05/2024 - 11/2009
2cariprazineIBA
01/2021 - 01/2019
2Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 01/2019
2LigandsIBA
01/2010 - 04/2008
2PK 11195 (PK11195)IBA
01/2010 - 04/2008
2A-factor (Streptomyces)IBA
01/2010 - 04/2008
2Oxytocin (Pitocin)FDA LinkGeneric
11/2009 - 07/2009
2GABA-A Receptors (GABA(A) Receptor)IBA
04/2008 - 09/2005
1VortioxetineIBA
05/2024
1SolutionsIBA
05/2024
1Psychotropic Drugs (Psychoactive Drugs)IBA
05/2021
1Silver Sulfadiazine (SSD)FDA LinkGeneric
04/2021
1Amisulpride (Solian)IBA
01/2019
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
01/2018
1BenzodiazepinesIBA
01/2018
1DiureticsIBA
01/2018
1Glycogen Synthase (Synthase I)IBA
01/2016
1LithiumIBA
01/2016
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2016
1erucylphosphocholineIBA
05/2015
13,4-methylenedioxyethamphetamine (MDEA)IBA
04/2014
1gamma-Aminobutyric Acid (GABA)IBA
05/2012
1Glutamic Acid (Glutamate)FDA Link
05/2012
1Biomarkers (Surrogate Marker)IBA
01/2010

Therapy/Procedure

3Therapeutics
01/2021 - 01/2017
1Transcranial Magnetic Stimulation
01/2024
1Personal Protective Equipment
02/2023
1Length of Stay
11/2019
1Pain Management
10/2017